Cantor Fitzgerald Maintains Fennec Pharmaceuticals (FENC) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on April 6, 2023,
Cantor Fitzgerald
maintained
coverage of Fennec Pharmaceuticals (NASDAQ:FENC) with
a Overweight recommendation.
Cantor Fitzgerald
maintained
coverage of Fennec Pharmaceuticals (NASDAQ:FENC) with
a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-how-to-trade-0dte-options-7481013-c9af6887219942dc9c8c9374963b51ec.jpg "How to Trade 0DTE Options")
